Navigation Links
Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
Date:9/18/2013

Los Angeles, CA (PRWEB) September 18, 2013

Some patients who have taken the statin drug Lipitor are reporting that they developed type 2 diabetes after taking the cholesterol-lowering drug despite having no known risk factors. High potency statin medications like Lipitor have been shown in some studies to increase a patient's risk of developing type 2 diabetes, a finding that many Lipitor patients say should have prompted the manufacturer of Lipitor to sufficiently warn patients of the drug’s type 2 diabetes risk before they began taking Lipitor.("Risk of Incident Diabetes Among Patients Treated with Statins: Population Based Study," May, 23, 2013, http://www.bmj.com/content/346/bmj.f2610) (In Re: Lipitor Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2459, JPMDL)

Manufactured by Pfizer, Lipitor's side effects started to come into focus when patients who had little risk of developing type 2 diabetes began to report that they developed type 2 diabetes while taking the drug. (In Re: Lipitor Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2459, JPMDL)

Responding to the allegations and recent studies, the Food and Drug Administration (FDA) has started to require that manufacturers of statin drugs list the associated blood sugar level risk on their warning levels. However, many patients allegedly injured by the statin claim in the Lipitor lawsuits that this warning did not come soon enough. (FDA Expands Advice on Statins Risks, February 27, 2012, http://www.fda.gov/forconsumers/consumerupdates/ucm293330.htm)

“When a medical drug or device has an associated risk or side effect, patients need to know,” said Laura Baughman, attorney at Baron and Budd. “The fact that Pfizer may not have sufficiently warn their patients of the type 2 diabetes risk associated with their very popular drug, Lipitor, is troubling."

To learn more about the associated risks of taking Lipitor, please visit http://baronandbudd.com/areas-of-practice/pharmaceuticals/lipitor-lawsuit/

To learn more about Baron and Budd’s handling of the Lipitor lawsuit or for a free consultation, please call 1.866.472.9108 or visit the firm’s website at http://baronandbudd.com.

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11133969.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit News: Bernstein Liebhard LLP Comments on Fresenius FDA Warning Letter, as GranuFlo Recall Claims Mount
2. Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
3. Warning Labels Update Survives Dismissal in Fosamax Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
4. Mental Health Watchdog Launches Psychiatric Drug Side Effects Database—Search All Drug Regulatory Agency Warnings, Studies & Adverse Reactions Reports
5. Injury Law Firm Releases New Informational Graphic Warning that Lead Poisoning is Still a Serious Risk in the United States
6. Zithromax Arrhythmia and Sudden Death Cases Allegations Update: Resource4thePeople Reports FDA Issued Warning Letter to Manufacturer over False and Misleading Information
7. AED.com Issues Warning to Consumers Concerning AED Scams
8. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Release of FDA Warning Letter to Intuitive Surgical
9. Vulcan Termite and Pest Control, Inc. Warning: Tiger Mosquito Invasion
10. Da Vinci Robot Lawsuits Continue as Alonso Krangle LLP Comments on Revelations in Intuitive Surgical Inc.’s FDA Warning Letter
11. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Comment on FDA Warning Letter Received by Intuitive Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... June 24, 2017 , ... Doorknobs are for convenience, deadbolts are ... getting a guard dog or having an alarm system installed. But unless there is ... entry. Yair Frenkel, owner of TX Premier Locksmith in Killeen, TX says: “In the ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... By scoring ... its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's ... top 1% of all charities reviewed by Charity Navigator and earns ANRF a spot ...
(Date:6/23/2017)... Va. (PRWEB) , ... June 23, 2017 , ... The ... the president's nominee for deputy secretary of Veterans Affairs, retired Marine Col. Thomas G. ... Veterans Affairs. , Bowman brings an intimacy with the issues and challenges ...
(Date:6/23/2017)... New York, NY (PRWEB) , ... June 23, 2017 , ... ... prefer to watch it while others prefer to read it, and some people don't ... printed versus visual pornography. Here's what they found: , Erotic literature can give readers ...
(Date:6/23/2017)... D.C. (PRWEB) , ... June 23, 2017 , ... ... during cooking is essential, and two new videos highlight the importance of correctly ... Specialist Christine Bruhn, Ph.D., who has done extensive research on consumer food safety ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017 The Bio Supply Management Alliance (BSMA) ... Fremont and the Biomedical Manufacturing Network to ... California by providing a platform ... fostering workforce development. The primary focus of this alliance ... as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... U.S. Food and Drug Administration (FDA) has notified the Company ... its Zhejiang, China manufacturing facility has ... successful clearance of the Warning Letter related to our ... measure of the progress we have made in our ongoing ...
(Date:6/11/2017)... INDIANAPOLIS , June 10, 2017  Eli Lilly and ... results from three Phase 3 studies of galcanezumab, an ... migraine, including late-breaking data on several key secondary endpoints ... Detailed results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) ... (AHS) annual scientific meeting in Boston ...
Breaking Medicine Technology: